Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD

High-sensitive C-reactive protein (hs-CRP) is one of the diagnostic components for metabolic (-dysfunction) associated fatty liver disease (MAFLD). This study aimed to explore the relationship between hs-CRP level and 25-year mortality in patients with MAFLD. The study data were from the Third Natio...

Full description

Bibliographic Details
Main Authors: Jiaofeng Huang, Mingfang Wang, Yinlian Wu, Rahul Kumar, Su Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2022.1012887/full
_version_ 1797985826850734080
author Jiaofeng Huang
Jiaofeng Huang
Mingfang Wang
Mingfang Wang
Yinlian Wu
Yinlian Wu
Rahul Kumar
Su Lin
Su Lin
author_facet Jiaofeng Huang
Jiaofeng Huang
Mingfang Wang
Mingfang Wang
Yinlian Wu
Yinlian Wu
Rahul Kumar
Su Lin
Su Lin
author_sort Jiaofeng Huang
collection DOAJ
description High-sensitive C-reactive protein (hs-CRP) is one of the diagnostic components for metabolic (-dysfunction) associated fatty liver disease (MAFLD). This study aimed to explore the relationship between hs-CRP level and 25-year mortality in patients with MAFLD. The study data were from the Third National Health and Nutrition Examination Survey 1988–1994. All participants were followed up until December 2015 and the outcome of each participant was ascertained from National Death Index records. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence interval (CI) of all-cause mortality, cardiovascular-related mortality, and malignancy-related mortality. A total of 4,145 participants with MAFLD were included in final analysis. The median follow-up period was 22.3 years (interquartile range 16.9–24.2). There were 1,610 (38.8%) all-cause deaths. The leading cause of death was malignant neoplasms (365/1,610, 22.7%), followed by cardiovascular diseases (342/1,610, 21.2%). Of the 4,145 patients with MAFLD, 1,293 (31.2%) had an hs-CRP level greater than 0.5 mg/dl. Those with hs-CRP > 0.5 mg/dl were older, more likely to be female and had greater derangements of metabolic profiles than those with lower hs-CRP. The results of Cox regression analysis showed that hs-CRP ≥ 0.5 mg/dl was an independent risk factor for all-cause mortality (HR = 1.394, 95% CI 1.253–1.551), cardiovascular mortality (HR = 1.497, 95% CI 1.190–1.885) and malignant neoplasms related mortality (HR = 1.290, 95% CI 1.030–1.615) after adjusting for risk factors. This study confirms that hs-CRP is an independent predictive factor of poor prognosis in patients with MAFLD.
first_indexed 2024-04-11T07:24:17Z
format Article
id doaj.art-6398d9df5c004f1d8019a81ee209efad
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-04-11T07:24:17Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-6398d9df5c004f1d8019a81ee209efad2022-12-22T04:37:07ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2022-10-011310.3389/fphys.2022.10128871012887Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLDJiaofeng Huang0Jiaofeng Huang1Mingfang Wang2Mingfang Wang3Yinlian Wu4Yinlian Wu5Rahul Kumar6Su Lin7Su Lin8Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, ChinaFujian Clinical Research Center for Liver and Intestinal Diseases, Fuzhou, Fujian, ChinaDepartment of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, ChinaFujian Clinical Research Center for Liver and Intestinal Diseases, Fuzhou, Fujian, ChinaDepartment of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, ChinaFujian Clinical Research Center for Liver and Intestinal Diseases, Fuzhou, Fujian, ChinaDepartment of Gastroenterology and Hepatology, Duke-NUS Academic Medical Centre, Changi General Hospital, Singapore, SingaporeDepartment of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, ChinaFujian Clinical Research Center for Liver and Intestinal Diseases, Fuzhou, Fujian, ChinaHigh-sensitive C-reactive protein (hs-CRP) is one of the diagnostic components for metabolic (-dysfunction) associated fatty liver disease (MAFLD). This study aimed to explore the relationship between hs-CRP level and 25-year mortality in patients with MAFLD. The study data were from the Third National Health and Nutrition Examination Survey 1988–1994. All participants were followed up until December 2015 and the outcome of each participant was ascertained from National Death Index records. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence interval (CI) of all-cause mortality, cardiovascular-related mortality, and malignancy-related mortality. A total of 4,145 participants with MAFLD were included in final analysis. The median follow-up period was 22.3 years (interquartile range 16.9–24.2). There were 1,610 (38.8%) all-cause deaths. The leading cause of death was malignant neoplasms (365/1,610, 22.7%), followed by cardiovascular diseases (342/1,610, 21.2%). Of the 4,145 patients with MAFLD, 1,293 (31.2%) had an hs-CRP level greater than 0.5 mg/dl. Those with hs-CRP > 0.5 mg/dl were older, more likely to be female and had greater derangements of metabolic profiles than those with lower hs-CRP. The results of Cox regression analysis showed that hs-CRP ≥ 0.5 mg/dl was an independent risk factor for all-cause mortality (HR = 1.394, 95% CI 1.253–1.551), cardiovascular mortality (HR = 1.497, 95% CI 1.190–1.885) and malignant neoplasms related mortality (HR = 1.290, 95% CI 1.030–1.615) after adjusting for risk factors. This study confirms that hs-CRP is an independent predictive factor of poor prognosis in patients with MAFLD.https://www.frontiersin.org/articles/10.3389/fphys.2022.1012887/fullMAFLDC-reactive proteinmortalityNHANESNAFLD
spellingShingle Jiaofeng Huang
Jiaofeng Huang
Mingfang Wang
Mingfang Wang
Yinlian Wu
Yinlian Wu
Rahul Kumar
Su Lin
Su Lin
Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
Frontiers in Physiology
MAFLD
C-reactive protein
mortality
NHANES
NAFLD
title Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
title_full Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
title_fullStr Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
title_full_unstemmed Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
title_short Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
title_sort serum high sensitive c reactive protein is a simple indicator for all cause among individuals with mafld
topic MAFLD
C-reactive protein
mortality
NHANES
NAFLD
url https://www.frontiersin.org/articles/10.3389/fphys.2022.1012887/full
work_keys_str_mv AT jiaofenghuang serumhighsensitivecreactiveproteinisasimpleindicatorforallcauseamongindividualswithmafld
AT jiaofenghuang serumhighsensitivecreactiveproteinisasimpleindicatorforallcauseamongindividualswithmafld
AT mingfangwang serumhighsensitivecreactiveproteinisasimpleindicatorforallcauseamongindividualswithmafld
AT mingfangwang serumhighsensitivecreactiveproteinisasimpleindicatorforallcauseamongindividualswithmafld
AT yinlianwu serumhighsensitivecreactiveproteinisasimpleindicatorforallcauseamongindividualswithmafld
AT yinlianwu serumhighsensitivecreactiveproteinisasimpleindicatorforallcauseamongindividualswithmafld
AT rahulkumar serumhighsensitivecreactiveproteinisasimpleindicatorforallcauseamongindividualswithmafld
AT sulin serumhighsensitivecreactiveproteinisasimpleindicatorforallcauseamongindividualswithmafld
AT sulin serumhighsensitivecreactiveproteinisasimpleindicatorforallcauseamongindividualswithmafld